Silva, R. B., Cheng, B., Carvajal, R. D., & Lee, S. M. (2024). Dose Individualization for Phase I Cancer Trials With Broadened Eligibility. Statistics in Medicine, 43(29), 5534–5547. Portico. https://doi.org/10.1002/sim.10264

Biard, L., Andrillon, A., Silva, R. B., & Lee, S. M. (2024). Dose optimization for cancer treatments with considerations for late-onset toxicities. Clinical Trials, 21(3), 322–330. https://doi.org/10.1177/17407745231221152